Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasm, Residual × Control Groups × 90 days × Clear all

Sponsor

Conditions

Neoplasms 3 Lung Neoplasms 2 Colorectal Neoplasms 2 Vomiting 1 Uterine Cervical Neoplasms 1 Ulcer 1 Stomatitis 1 Sleep Initiation and Maintenance Disorders 1 Pediatric Brain Tumor 1 Pathologic Processes 1 Papillomavirus Infections 1 Nausea 1 Motor Activity 1 Lymphatic Metastasis 1 Liver Diseases 1 Liver Cirrhosis 1 Keratosis, Actinic 1 Hematologic Neoplasms 1 Gastrostomy 1 Fatigue 1 Disease 1 Cancer Pain 1 Breast Neoplasms 1

Interventions

Cyclophosphamide 5 fludarabine 4 Dexamethasone 4 blinatumomab 3 Lenalidomide 3 pembrolizumab 2 fludarabine phosphate 2 Cytarabine 2 venetoclax 1 tislelizumab 1 tisagenlecleucel 1 tetrathiomolybdate 1 tagraxofusp 1 relugolix 1 obinutuzumab 1 nilotinib 1 ixazomib 1 isatuximab 1 inavolisib 1 giredestrant 1 enzalutamide 1 daratumumab 1 abemaciclib 1 Vincristine 1 Transplantation 1 Radiotherapy 1 Neoadjuvant Therapy 1 Monatide (IMS 3015) 1 Methotrexate 1 Melphalan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡